Scarica l'app Stockscreener
397.97
1.28%
-5.14
Pre-mercato:
400.40
2.43
+0.61%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics president sells shares worth $3.7 million - MSN
Buybacks Report: Is United Therapeutics Corporation affected by consumer sentimentRisk Management & Verified Entry Point Detection - خودرو بانک
United Therapeutics Corporation $UTHR Shares Acquired by Ashton Thomas Private Wealth LLC - MarketBeat
United Therapeutics Corporation $UTHR Holdings Lifted by Acadian Asset Management LLC - MarketBeat
Fred Alger Management LLC Takes Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Jan Malcolm Sells 700 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 5,000 Shares - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 11,375 Shares of Stock - MarketBeat
Growth Value: What is United Therapeutics Corporation’s valuation compared to sectorRisk Management & Stepwise Swing Trade Plans - خودرو بانک
Swedbank AB Lowers Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $525.00 at Cantor Fitzgerald - MarketBeat
Axiom Investors LLC DE Has $500,000 Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Integrated Wealth Concepts LLC - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 25,289 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Jacobs Levy Equity Management Inc. Grows Stake in United Therapeutics Corporation $UTHR - MarketBeat
Inspire Investing LLC Sells 1,237 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Royal Bank of Canada Purchases 32,867 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Advisors Asset Management Inc. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 4,560 Shares of Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 8,000 Shares - MarketBeat
Talon Private Wealth LLC Grows Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
21,112 Shares in United Therapeutics Corporation $UTHR Acquired by Capital Impact Advisors LLC - MarketBeat
Major IPF Treatment Breakthrough: United Therapeutics Reveals TETON-2 Trial Results at European Congress - Stock Titan
Cantor Fitzgerald Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock - Defense World
Equities Analysts Issue Forecasts for UTHR FY2026 Earnings - Defense World
Amundi Has $107.64 Million Stake in United Therapeutics Corporation $UTHR - MarketBeat
Federation des caisses Desjardins du Quebec Purchases 936 Shares of United Therapeutics Corporation $UTHR - MarketBeat
3 High-Growth Stocks Poised to Extend Gains Into Year-End - Investing.com
United Therapeutics stock maintains Buy rating at UBS on IPF opportunity - Investing.com Nigeria
United Therapeutics stock maintains Buy rating at UBS on IPF opportunity By Investing.com - Investing.com South Africa
Empowered Funds LLC Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Services Automobile Association Invests $876,000 in United Therapeutics Corporation $UTHR - MarketBeat
Dynamic Technology Lab Private Ltd Invests $867,000 in United Therapeutics Corporation $UTHR - MarketBeat
Clark Capital Management Group Inc. Has $29.09 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Hancock Whitney Corp Has $2.04 Million Position in United Therapeutics Corporation $UTHR - MarketBeat
Cantor Fitzgerald Raises Price Target for United Therapeutics (U - GuruFocus
United Therapeutics stock price target raised to $525 by Cantor Fitzgerald - Investing.com
United Therapeutics Corporation (NASDAQ:UTHR) Sees Significant Increase in Short Interest - MarketBeat
HC Wainwright Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Alliancebernstein L.P. - MarketBeat
United Therapeutics Corporation $UTHR Stake Cut by Nitorum Capital L.P. - MarketBeat
Brokerages Set United Therapeutics Corporation (NASDAQ:UTHR) PT at $429.62 - MarketBeat
United Therapeutics (UTHR): Evaluating Valuation After Breakthrough IPF Trial Results Drive Analyst Upgrades - simplywall.st
RSI Suggests Rebound May Be Near in United Therapeutics CorporationCEO Change & Reliable Entry Point Trade Alerts - beatles.ru
Parkman Healthcare Partners LLC Decreases Stake in United Therapeutics Corporation $UTHR - MarketBeat
Does United Therapeutics Corporation have declining or rising EPSTrade Entry Report & Stepwise Trade Signal Guides - beatles.ru
United Therapeutics (NASDAQ:UTHR) Trading Down 4.8% Following Insider Selling - MarketBeat
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio? - Benzinga
MPM Bioimpact LLC Boosts Position in United Therapeutics Corporation $UTHR - MarketBeat
1.11%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):